DJ Novavax Inc. Stock Underperforms Wednesday When Compared To Competitors
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Novavax Inc. $(NVAX)$ slid 1.47% to $8.02 Wednesday, on what proved to be an all-around great trading session for the stock market, with the NASDAQ Composite Index rising 1.16% to 21,840.95 and the Dow Jones Industrial Average rising 0.48% to 46,565.74.
Novavax Inc. closed 33.00% short of its 52-week high of $11.97, which the company reached on February 26th.
The stock underperformed when compared to some of its competitors Wednesday, as Johnson & Johnson $(JNJ)$ fell 0.13% to $244.12, Pfizer Inc. $(PFE)$ rose 1.67% to $28.55, and Merck & Co. Inc. $(MRK)$ rose 0.46% to $120.84.
Trading volume (2.8 M) remained 2.5 million below its 50-day average volume of 5.2 M.
Data source: Dow Jones Market Data, FactSet. Data compiled April 1, 2026.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
April 01, 2026 17:28 ET (21:28 GMT)
Copyright (c) 2026 Dow Jones & Company, Inc.
Comments